Filing Details
- Accession Number:
- 0000899243-20-030622
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-09 16:05:09
- Reporting Period:
- 2020-11-06
- Accepted Time:
- 2020-11-09 16:05:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1519218 | Andrew Okun | 940 Winter Street Waltham MA 02451 | Please See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-06 | 6,107 | $81.29 | 16,417 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-06 | 6,107 | $140.14 | 10,310 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | NQ Stock Option (right to buy) | Disposition | 2020-11-06 | 6,107 | $0.00 | 6,107 | $81.29 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,054 | 2025-01-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 8 | Indirect | By 401(K) |
Footnotes
- The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
- The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Okun on September 3, 2020.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.05 to $140.28. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three equal annual installments beginning on January 30, 2019, which was the first anniversary of the date on which the option was granted.